Search Results - "Felace, G."

Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study by Fadini, G. P., Li Volsi, P., Devangelio, E., Poli, M., Cazzetta, G., Felace, G., Avogaro, A.

“…Background and aims In routine clinical practice, early discontinuation of newly initiated glucose-lowering medications (GLM) is relatively common. We herein…”
Get full text

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity by Fadini, G P, Zatti, G, Consoli, A, Bonora, E, Sesti, G, Avogaro, A

“…Randomized controlled trials (RCTs) in the field of diabetes have limitations inherent to the fact that design, setting, and patient characteristics may be…”
Get full text

Bruising: A Neglected, Though Patient-Relevant Complication of Insulin Injections Coming to Light from a Real-Life Nationwide Survey by Gentile, Sandro, Guarino, Giuseppina, Della Corte, Teresa, Marino, Giampiero, Satta, Ersilia, Romano, Carmine, Alfrone, Carmelo, lmberti, Clelia, Strollo, Felice

“…Introduction Despite the availability of sophisticated devices and suitable recommendations on how to best perform insulin injections, lipohypertrophy (LH) and…”
Get full text

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes) by Fadini, G.P., Zatti, G., Consoli, A., Bonora, E., Sesti, G., Avogaro, A., Consoli, A., Formoso, G., Antenucci, D., Grossi, G., Pucci, A., Sesti, G., Andreozzi, F., Indrieri, L., Capobianco, G., Gatti, A., Bonadonna, R., Zavaroni, I., Dei Cas, A., Felace, G., Li Volsi, P., Buzzetti, R., Leto, G., D'Angelo, F., Morano, S., Giaccari, A., Sorice, G., Orsi, E., Carlo Bossi, A., Querci, F., Duratorre, E., Malagola, C., Franzetti, I., Silvia Morpurgo, P., Boemi, M., Petrelli, M., Aimaretti, G., Karamouzis, I., Cavalot, F., Saglietti, G., Gruden, G., Devangelio, E., Cazzetta, G., Lamacchia, O., Cervone, S., Frittitta, L., Arena, S., Di Benedetto, A., Piro, S., Giordano, C., Rizzo, M., Chianetta, R., Mannina, C., Solini, A., Natali, A., Anichini, R., Dotta, F., Fattor, B., Avogaro, A., Fadini, G.P., Bonora, E., Cigolini, M., Simioni, N., Frison, V., Poli, M., Lapolla, A., Cristiano Chilelli, N., Vinci, C.

“…Randomized controlled trials (RCTs) in the field of diabetes have limitations inherent to the fact that design, setting, and patient characteristics may be…”
Get full text